HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

NEBCIN overview

Treatment of the following infections caused by susceptible micro-organisms: central nervous system infections (including meningitis, septicaemia and neonatal sepsis); gastrointestinal infections (including peritonitis, complicated and recurrent urinary tract infections); lower respiratory tract infections (including pneumonia, bronchopneumonia and acute bronchitis); skin, bone and soft tissue infections (including burns).

Tobramycin is usually active against most strains of the following organisms: Pseudomonas aeruginosa; Proteus species (indole positive and indole negative), including Pr. mirabilis, Pr. rettgeri and Pr. vulgaris; Morganella morganii; vulgaris; Morganella morganii; Escherichia coli; Klebsiella- Enterobacter-Serratia species; Citrobacter species; Providencia species; Staphylococci including Staphylococcus aureus (coagulase-positive and coagulase-negative).

banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
NEBCIN
Drug Class Description :

Aminoglycosides.

Generic Name :

Tobramycin

Drug description :

Solution in vials.

Presentation :

Injection, tobramycin (as sulphate) 20, 40 and 80 mg .

Indications :

Treatment of the following infections caused by susceptible micro-organisms: central nervous system infections (including meningitis, septicaemia and neonatal sepsis); gastrointestinal infections (including peritonitis, complicated and recurrent urinary tract infections); lower respiratory tract infections (including pneumonia, bronchopneumonia and acute bronchitis); skin, bone and soft tissue infections (including burns).

Tobramycin is usually active against most strains of the following organisms: Pseudomonas aeruginosa; Proteus species (indole positive and indole negative), including Pr. mirabilis, Pr. rettgeri and Pr. vulgaris; Morganella morganii; vulgaris; Morganella morganii; Escherichia coli; Klebsiella- Enterobacter-Serratia species; Citrobacter species; Providencia species; Staphylococci including Staphylococcus aureus (coagulase-positive and coagulase-negative).

Adult Dosage :

3 - 5 mg/kg daily in three or four divided doses by intramuscular injection or intravenous injection or infusion.

Child Dosage :

Neonates, up to 4 mg/kg daily in two equal doses; others, 6 - 7.5 mg/kg daily in three or four divided doses.

Contra Indications :

Pregnancy, lactation.

Special Precautions :

Renal impairment; control blood levels and dosage.

Interactions :

Other aminoglycosides, loop diuretics, neuromuscular blocking agents.

Adverse Reactions :

Anaphylaxis, ototoxicity, nephrotoxicity. Raised liver enzymes.

Manufacturer :

King

Drug Availability :

(POM)

Drug Updated :

24 June 2009

Related Drugs - Antibiotics & antibacterials
Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Ophthalmics - understanding, management, diagnosis and treatment information Parkinson's disease (PD) is a degenerative disorder of the central nervous system characterized by the clinically asymmetric onset of resting tremor, bradykinesia, rigidity and postural instability. Cystic Fibrosis
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES